Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Real-world efficacy and safety of eribulin in advanced and pretreated HER2-negative breast cancer in a Spanish comprehensive cancer center

Fig. 1

Kaplan Meier curves for overall survival. a KM curves for TNBC compared to HR-positive tumors. Median OS was significantly shorter in patients with TNBC compared to ER-positive tumors. b KM for OS for burden of disease (< 2 organs involved compared to > 2 organs involved). mOS was significantly shorter in patients with more than 2 organs involved compared to those with 2 or less M1. c KM for OS for patients with visceral involvement compared to non-visceral involvement. mOS was significantly shorter in patients with visceral involvement compared to those without visceral M1. d KM curves for OS for patients younger than 70 years of age compared to older than 70 years of age. mOS was significantly shorter in patients younger than 70 years of age compared to those older. Abbreviations: KM: Kaplan Meier; OS: overall survival; TNBC: triple-negative breast cancer; m: months; ER: estrogen receptor; mOS: median overall survival; CI: confidence interval; M1: metastases; HR: hazard ratio; m: months

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us